These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9411716)

  • 21. Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review.
    Agabio R; Pani PP; Preti A; Gessa GL; Franconi F
    Eur Addict Res; 2016; 22(1):1-16. PubMed ID: 26314552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent results in relaps prevention of alcoholism with Disulfiram].
    Mutschler J; Diehl A; Vollmert C; Herre H; Mann K; Kiefer F
    Neuropsychiatr; 2008; 22(4):243-51. PubMed ID: 19080995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acamprosate (Aotal): could adverse effects upset the treatment of alcohol dependence?].
    Oscar MA; Bataillon C; Bagheri H; Le Quellec A; Rolland F; Montastruc JL
    Therapie; 2003; 58(4):371-4. PubMed ID: 14679678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.
    de Sousa A; de Sousa A
    Alcohol Alcohol; 2005; 40(6):545-8. PubMed ID: 16043433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the treatment of alcohol dependence: pharmacological relapse prevention].
    Smolka MN; Kiefer F; Mann K
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():65-9. PubMed ID: 15490769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acamprosate.
    Drugs R D; 2002; 3(1):13-8. PubMed ID: 11881522
    [No Abstract]   [Full Text] [Related]  

  • 27. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current aspects of pharmacotherapy of alcoholism].
    Schmidt LG; Dufeu P; Kuhn S; Rommelspacher H
    Nervenarzt; 1995 May; 66(5):323-30. PubMed ID: 7609812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical pharmacology of acamprosate.
    Kalk NJ; Lingford-Hughes AR
    Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing the desire to drink. Pharmacology and neurobiology.
    Litten RZ; Allen JP
    Recent Dev Alcohol; 1993; 11():325-44. PubMed ID: 8234930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of alcohol dependence].
    Soyka M
    MMW Fortschr Med; 2008 May; 150 Suppl 2():22-4. PubMed ID: 18680838
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
    Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
    Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.